Clinical trial
Citrate Versus Heparin in Continuous Renal Replacement Therapy : Effect on Cardiovascular System and Clot Circuit in Critically Ill Patients
NCT04865510 is registered in ClinicalTrials.gov with Bangkok Metropolitan Administration Medical College and Vajira Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Citrate Versus Heparin in Continuous Renal Replacement Therapy : Effect on Cardiovascular System and Clot Circuit in Critically Ill Patients
- Lead sponsor
- Bangkok Metropolitan Administration Medical College and Vajira Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 4, 2019
- Completion date
- March 31, 2021
- Enrollment
- 41 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, citrate, cytokines, hemodynamic responses